Daniel M. Skovronsky
2018
In 2018, Daniel M. Skovronsky earned a total compensation of $5.1M as Senior Vice President and Chief Scientific Officer at Lilly Eli & Co.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $75,717 |
|---|---|
| Non-Equity Incentive Plan | $1,376,431 |
| Salary | $837,500 |
| Stock Awards | $2,806,000 |
| Other | $50,250 |
| Total | $5,145,898 |
Skovronsky received $2.8M in stock awards, accounting for 55% of the total pay in 2018.
Skovronsky also received $75.7K of change in pension value and nonqualified deferred compensation earnings, $1.4M in non-equity incentive plan, $837.5K in salary and $50.3K in other compensation.
Rankings
In 2018, Daniel M. Skovronsky's compensation ranked 1,933rd out of 14,244 executives tracked by ExecPay. In other words, Skovronsky earned more than 86.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,933 out of 14,244 | 86th |
Division Manufacturing | 698 out of 5,765 | 88th |
Major group Chemicals And Allied Products | 231 out of 2,128 | 89th |
Industry group Drugs | 183 out of 1,817 | 90th |
Industry Pharmaceutical Preparations | 141 out of 1,391 | 90th |
Source: SEC filing on March 22, 2019.
Skovronsky's colleagues
We found five more compensation records of executives who worked with Daniel M. Skovronsky at Lilly Eli & Co in 2018.
2018
David Ricks
Lilly Eli & Co
Chief Executive Officer
2018
Michael Harrington
Lilly Eli & Co
General Counsel
2018
Jeffrey Simmons
Lilly Eli & Co
Chief Executive Officer
2018
Joshua Smiley
Lilly Eli & Co
Chief Financial Officer
2018
Enrique Conterno
Lilly Eli & Co